Accessibility Information

Users of assistive technologies such as screen readers should use the following link to activate Accessibility Mode before continuing: Learn more and Activate accessibility mode.

A--Development and FDA Licensure of a Bioscavenger Prophylactic

Solicitation Number: W911QY-13-C-0056
Agency: Department of the Army
Office: Army Contracting Command
Location: ACC-APG - Natick (SPS)
  • Print

Note:

There have been modifications to this notice. You are currently viewing the original synopsis. To view the most recent modification/amendment, click here
:
W911QY-13-C-0056
:
Award Notice
:
May 9, 2013
:
W911QY-13-C-0056
:
$156,621,207.00
:
0001
:
014130053
:
DYNPORT VACCINE COMPANY LLC (014130053)
64 THOMAS JOHNSON DR
FREDERICK, MD 21702-4300
:
Added: May 10, 2013 2:19 pm
This contract action was not awarded as a fixed price type because uncertainties involved in contract performance did not permit costs to be estimated with sufficient accuracy to use any type of fixed price contract. As such, a cost-reimbursement type action was awarded (FAR 16.301-2).

FDA approved countermeasure that will increase the likelihood that a Warfighter will maintain operational effectiveness following nerve agent exposure, specifically a drug or biologic intended for use prior to an exposure to nerve agent, i.e., a prophylactic countermeasure. It is anticipated that the countermeasure, when administered prior to nerve agent exposure, shall decrease incapacitation and death associated with nerve agent poisoning. Specifically, when administered prior to nerve agent exposure, the countermeasure should prevent injury by binding and sequestering or degrading nerve agent in the circulatory system before it can reach the nervous system.
:
ACC-APG - Natick (SPS), ATTN: AMSRD-ACC-N, Natick Contracting Division (R and BaseOPS), Building 1, Kansas Street, Natick, MA 01760-5011
:
Leo Fratis, (301)619-7421

ACC-APG - Natick (SPS)